follicular thyroid cancer
Showing 1 - 11 of 11
Studies on Tumors of the Thyroid
Recruiting
- Hurthle Cell Thyroid Cancer
- +4 more
- 68-Gallium Dotatate
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)
Not yet recruiting
- Thyroid Cancer
- +5 more
- Selpercatinib
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Dec 20, 2022
Thyroglobulin and Galectin-3 for Prognosis and Follow-up in
Recruiting
- Thyroid Cancer
- +2 more
-
Taipei, TaiwanChih-Yuan Wang, M.D
Oct 16, 2022
Pathological Manifestation in Thyroid Follicular Neoplasm: Early
Not yet recruiting
- Thyroid Cancer
- Follicular Thyroid Cancer
- (no location specified)
Jul 20, 2022
Aberrant Helix Pomatia Agglutinin Binding Glycan Expression in
Completed
- Follicular Thyroid Cancer
- Lectin-histochemistry retrospectively performed
-
Singapore, SingaporeNational University Hospital
Sep 25, 2021
Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer Trial in Tampa (Lenvatinib, Sorafenib, Cabozantinib)
Terminated
- Thyroid Cancer
- +5 more
- Lenvatinib
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jul 12, 2021
Synthetic Thyroid Hormone for Thyroid Cancer Treatment
Completed
- Malignant Struma Ovarii
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 25, 2020
Papillary Thyroid Cancer, Follicular Thyroid Cancer, Differentiated Thyroid Cancer Trial in Washington (SU011248, Sutent)
Completed
- Papillary Thyroid Cancer
- +2 more
- SU011248, Sutent
-
Washington, District of ColumbiaMedStar Washington Hospital Center
Aug 3, 2020
Follicular Thyroid Cancer Trial in Marseille (sophrology sessions)
Unknown status
- Follicular Thyroid Cancer
- sophrology sessions
-
Marseille, Paca, FranceAssistance Publique Des Hopitaux de Marseille
Aug 17, 2018
Papillary Thyroid Cancer, Follicular Thyroid Cancer, Huerthle Cell Thyroid Cancer Trial in United States (rosiglitazone, XL184)
Completed
- Papillary Thyroid Cancer
- +3 more
-
Duarte, California
- +4 more
Sep 17, 2013